Tolerance to a drug means the drug's effect diminishes with the same dosage; a higher dose is needed for the same effect.
This is depicted as a rightward shift in the dose-response curve: dose on the x-axis, effect on the y-axis.
Tolerance is a form of negative feedback, where the body tries to maintain homeostasis.
Homeostasis involves maintaining certain parameters within acceptable limits.
The body compensates for drug effects through negative feedback mechanisms.
These mechanisms can be:
Fast (e.g., body temperature, blood pressure regulation).
Slow (e.g., changes in drug elimination or receptor characteristics).
Tolerance is an active response that takes time to develop: repeated or continuous exposure leads to a tolerance response.
Tolerance mechanisms may involve:
Better drug elimination.
Changes in the number or type of receptors.
Alterations in intracellular processes.
Tolerance isn't limited to drugs of abuse; common medications like ibuprofen can also lead to tolerance.
Tolerance mechanisms don't disappear immediately after drug use stops.
These mechanisms persist, pushing the body away from homeostasis in the opposite direction, leading to withdrawal effects.
Withdrawal Effects
Withdrawal effects are the body's tolerance mechanisms acting in the absence of the drug.
These effects are opposite to the drug's original effects (e.g., insomnia from sleeping pill withdrawal, increased pain from pain medication withdrawal).
Withdrawal symptoms diminish over time as the body returns to homeostasis.
The duration of withdrawal varies depending on the drug.
Withdrawal symptoms are indicative of physical dependence on a drug.
The easiest way to alleviate withdrawal symptoms is to take the drug, reinforcing dependence.
When discontinuing a drug after long-term use, it should be done slowly and under supervision to minimize withdrawal effects.
Nicotine patches or gum are examples of methods used to gradually reduce drug intake.
Context-Dependent Tolerance
Tolerance can be classically conditioned to the context in which the drug is taken.
Addicts often associate drug-taking with specific places or people.
The context becomes a conditioned stimulus that triggers the tolerance response.
Overdose can occur in novel environments where the context doesn't trigger the tolerance response, leading to a greater effect from the same dose.
Withdrawal symptoms can be triggered by familiar environments associated with drug use, even after detoxification.
Relapse can occur when returning to these environments due to the triggered withdrawal symptoms.
Tolerance varies among drugs due to different mechanisms and time frames.
Tolerance can be triggered by a context, leading to drug-seeking behavior, or can be dangerous in a new context due to the lack of a tolerance response.
Psychological Dependence
Psychological dependence has a neurobiological basis.
Instrumental or operant conditioning plays a key role: a stimulus triggers a behavior that leads to a reward, reinforcing the behavior.
A brain system must reinforce behaviors that lead to evolutionarily important rewards (e.g., food, sex).
Older and Milner discovered a reinforcement system in the brain by accidently stimulating a rat's brain whilst the rat was in a specific point of the maze.
They decided to proceed by mapping out the brain by intracranial self-stimulation in rats; the rats would press a lever to receive electrical stimulation.
Mapping of the brain revealed locations where stimulation would reward a behavior.
Neuroanatomical Terminology
During brain development, the neural tube forms three primary vesicles: the forebrain, midbrain, and hindbrain.
The forebrain divides into the telencephalon (cortex, basal ganglia) and diencephalon (thalamus, hypothalamus).
The midbrain remains the mesencephalon.
The hindbrain divides into the metencephalon (pons, cerebellum) and myelencephalon (medulla oblongata).
The cortex in humans is so large that it covers most other structures.
The brain can be thought of as five major subdivisions: medulla, pons/cerebellum, midbrain, diencephalon, and cortex/basal ganglia.
Reward System
The nucleus accumbens and ventral tegmental area (VTA) are key components of the reward system.
These are part of the mesotelencephalic dopamine system, connecting the midbrain to the telencephalon via dopamine.
The system includes dopamine as a neurotransmitter, and substantia nigra to the striatum connection.
The VTA contains dopaminergic neurons that project to the nucleus accumbens, forming synapses.
The medial forebrain bundle is a bundle of axons running from the mesencephalon to the telencephalon, using dopamine as the neurotransmitter.
Electrical stimulation of the medial forebrain bundle triggers dopamine release.
Dopamine levels in the nucleus accumbens increase during rewarding activities.
Dopamine and Reward
Stella, Kelly, and Corbett demonstrated that blocking dopamine receptors in the nucleus accumbens prevents rats from learning to press a lever for stimulation.
This indicates that dopamine release is crucial for the rewarding effect.
The VTA-to-nucleus accumbens dopamine release is a key part of the reinforcement system.
Dopamine also relates to wanting and seeking rather than just pleasure.
Dopamine is released during both reward and punishment.
Dopamine release is more related to gathering information and the compulsion to repeat behaviors.
Dopamine and Addiction
Drug addicts crave drugs even when they no longer enjoy the effects.
The dopamine system drives animals to do things that increase their fitness, regardless of whether they like it.
Cocaine and amphetamines increase dopamine levels, making them psychologically addictive.
Self-injection experiments in rats show that dopamine levels increase with drug use.
Infusing cocaine directly into the nucleus accumbens leads to self-administration, indicating a direct effect on the mesotelencephalic dopamine system.
Addictive drugs bypass the brain's assessment systems and directly activate dopamine release in the nucleus accumbens.
This leads to a compulsion to take the drug again in the future.
Review Questions
Dopamine release from VTA neurons into the nucleus accumbens is a crucial step in the reinforcement system.
Dopamine receptor blockers have the potential to prevent the development of addiction but may be less effective once the psychological addiction is established.
Dopamine also drives exploration and makes the animal do that behaviour more likely again in the future.
Summary
Pharmacokinetics involves drug absorption, distribution, and elimination, with different drugs having different parameters.
Physical drug dependence results from drug tolerance and withdrawal symptoms.
Psychological dependence is due to activation of the VTA and nucleus accumbens connection, involved in the rewarding or seeking system; the drug bypasses other systems to directly get into that pathway.
Drugs that cross the blood-brain barrier are lipophilic and affect areas with dopamine neurotransmitters.